• About Luminesce Alliance Enabling Platforms Program

    About Luminesce Alliance Enabling Platforms Program

    Read More
  • Enabling Platform – Functional Genomics

    Enabling Platform – Functional Genomics

    Read More
  • Enabling Platform – Data

    Enabling Platform – Data

    Read More
  • Enabling Platform – Precision Therapy

    Enabling Platform – Precision Therapy

    Read More
  • Enabling Platform – Psychosocial

    Enabling Platform – Psychosocial

    Read More
  • Enabling Platform – Health Systems Implementation and Economics

    Enabling Platform – Health Systems Implementation and Economics

    Read More
  • Paediatric Precision Medicine

    Paediatric Precision Medicine

    Read More
  • Functional Genomics

    Functional Genomics

    Read More
  • Clinical Trials

    Clinical Trials

    Read More
  • Computational Biology

    Computational Biology

    Read More
  • Predisposition Screening for Paediatric Cancers

    Predisposition Screening for Paediatric Cancers

    Read More
  • Predisposition Screening for Paediatric Rare Diseases

    Predisposition Screening for Paediatric Rare Diseases

    Read More
  • Integrated Data Linkage System – Predictive Analysis

    Integrated Data Linkage System – Predictive Analysis

    Read More
  • Inherited Retinal Diseases – Health Economics and Health Implementation

    Inherited Retinal Diseases – Health Economics and Health Implementation

    Read More
  • Cancer – Health Economics and Health Implementation

    Cancer – Health Economics and Health Implementation

    Read More
  • Psychosocial Implications of Precision Medicine

    Psychosocial Implications of Precision Medicine

    Read More
  • Newborn Screening Program Pilot for Spinal Muscular Atrophy and Primary Immunodeficiency in NSW & ACT

    Newborn Screening Program Pilot for Spinal Muscular Atrophy and Primary Immunodeficiency in NSW & ACT

    Read More
  • Establishment of small-scale cGMP vector manufacturing for gene and cell therapy clinical trials – laying the foundations for national large scale capacity

    Establishment of small-scale cGMP vector manufacturing for gene and cell therapy clinical trials – laying the foundations for national large scale capacity

    Read More
  • INFORM2: An exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with high risk Malignancies

    INFORM2: An exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with high risk Malignancies

    Read More

Luminesce Alliance - reflects our vision of illuminating our groundbreaking medical discoveries changing children’s health around the world.

Learn more

Acknowledgment of Country.

In the spirit of reconciliation, the Luminesce Alliance acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community.

We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.